Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Argipressin on Blood Loss During Hepatic Resection; a Double-blinded, Randomized Placebo-controlled Trial (ARG-01)

NCT05293041 is registered in ClinicalTrials.gov with Kristina Svennerholm as lead sponsor.

NCT NCT05293041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Argipressin on Blood Loss During Hepatic Resection; a Double-blinded, Randomized Placebo-controlled Trial (ARG-01)
Lead sponsor
Kristina Svennerholm
Phase
Phase 4
Overall status
Completed
Start date
March 27, 2022
Completion date
February 17, 2025
Enrollment
248 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer liver metastasis, inflammatory response, vasopressin causing adverse effects in therapeutic use